News-Medical.Net Urinary Tract Infection News Feed
New guideline recommends first-trimester screening of pregnant women for asymptomatic bacteriuria
Mon, 09 Jul 2018 03:50:01 -0400
First-trimester screening of pregnant women for asymptomatic bacteriuria -- higher than normal bacteria levels without symptoms of a bladder infection -- is recommended by the Canadian Task Force on Preventive Health Care in an updated guideline in CMAJ
CMS policy had insignificant impact on reducing healthcare-associated infections
Mon, 02 Jul 2018 02:41:09 -0400
Hospitals may have avoided financial penalties by billing hospital-associated conditions as present at the time of the patient's admission, supporting prior work that showed that a Medicare policy designed to monetarily penalize hospitals for preventable complications had an insignificant impact on reducing healthcare-associated infections.
Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA
Mon, 25 Jun 2018 10:02:01 -0400
Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted for standard review a new supplemental Biologics License Application for KEYTRUDA, Merck's anti-PD-1 therapy, as adjuvant therapy in the treatment of patients with resected, high-risk stage III melanoma and granted a Prescription Drug User Fee Act, or target action, date of February 16, 2019.
Study: Lenabasum has acceptable safety and tolerability in diffuse cutaneous systemic sclerosis
Mon, 18 Jun 2018 03:02:05 -0400
The results of an open label extension of a phase II study presented today at the Annual European Congress of Rheumatology, 2018, demonstrate that lenabasum continues to have acceptable safety and tolerability in diffuse cutaneous systemic sclerosis with no severe or serious adverse events.
That ‘living will’ you signed? At the ER, it could be open to interpretation.
Thu, 14 Jun 2018 05:48:10 -0400
"Don't resuscitate this patient; he has a living will," the nurse told Dr. Monica Williams-Murphy, handing her a document.
Critical access hospitals face problems in infection prevention and control practices, shows research
Wed, 13 Jun 2018 03:35:03 -0400
Critical access hospitals face significant challenges in their infection prevention and control practices, according to new research presented at the 45th Annual Conference of the Association for Professionals in Infection Control and Epidemiology.
Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients
Fri, 01 Jun 2018 10:26:03 -0400
Bristol-Myers Squibb Company today announced patient-reported outcomes data from the Phase 3 CheckMate -214 trial in intermediate- and poor-risk patients with advanced renal cell carcinoma treated with the Immuno-Oncology combination Opdivo plus low-dose Yervoy versus sunitinib over a two-year follow-up period.
Study: Medicaid expansion linked to reduction in ICU utilization
Wed, 23 May 2018 01:32:36 -0400
A new study suggests that states that expanded their Medicaid programs under the Patient Protection and Affordable Care Act (PPACA) saw a decline in ICU utilization among patients hospitalized for conditions for which hospitalizations may have been prevented through early interventions.
Oral antibiotic use may increase risk of developing kidney stones, shows study
Fri, 11 May 2018 06:29:09 -0400
Pediatric researchers have found that children and adults treated with some oral antibiotics have a significantly higher risk of developing kidney stones.
Study: One-third of bacterial infections in patients with cirrhosis induced by MDR bacteria
Fri, 13 Apr 2018 07:01:12 -0400
A worldwide study initiated to investigate the epidemiology and outcomes of bacterial infections in hospitalized patients with liver cirrhosis has reported a prevalence of multi-drug-resistant bacteria of 34% and significant regional differences in the risk of developing a multi-drug-resistant infection.